Evaluating the safety of preventive chemotherapy in special groups. 1. FundingWHO2. CollaboratorsDr Mduluza, University of ZimbabweDr Nicholas Midzi, NIHR Zimbabwe3. Field workMurewa district in Zimbabwe This article was published on Monday 17 June 2024
